Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
pbserum HA 2.0
- Development stage
- Unknown
- Lead developer
- Proteos Biotech
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Administration
- Intradermal, Subcutaneous
01
Overview
pbserum HA 2.0 is an injectable bioremodeling treatment developed by Proteos Biotech. It is a combination therapy consisting of high-molecular-weight, non-crosslinked hyaluronic acid and a recombinant enzymatic system containing collagenase (Col G/H PB220), lipase (PB500), and lyase (PB72K). The product is designed to treat dermatological conditions associated with fibrotic processes, such as pathological scars (hypertrophic and keloid), post-surgical or post-procedural fibrosis, cellulite, and localized adiposity. Hyaluronic acid provides hydration, anti-inflammatory effects, and a physical barrier to prevent fibrotic adhesions, while the recombinant enzymes synergistically degrade excess collagen, metabolize localized fat deposits, and break down proteoglycans to remodel fibrotic tissue and improve skin elasticity.
- Brand names
- PBSerum HA 2.0WAID Injectable
- Other names
- PBSerum HA2.0
02
Targets
FMOD (Fibromodulin / FMOD)
Beyond the preview
Go deeper on pbserum HA 2.0.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on pbserum HA 2.0.